Table 2 Relationship between CHPF expression and tumor characteristics in patients with gastric cancer.
From: CHPF promotes gastric cancer tumorigenesis through the activation of E2F1
Features | No. of patients | CHPF expression | P value | |
---|---|---|---|---|
Low | High | Â | ||
All patients | 140 | 85 | 55 | Â |
Age (years) | Â | Â | Â | 0.074 |
 <58 | 68 | 47 | 21 |  |
 ≥58 | 70 | 38 | 32 |  |
Gender | Â | Â | Â | 0.619 |
 Male | 80 | 50 | 30 |  |
 Female | 60 | 35 | 25 |  |
Grade | Â | Â | Â | 0.333 |
 1 | 1 | 1 | 0 |  |
 2 | 16 | 10 | 6 |  |
 3 | 110 | 68 | 42 |  |
 4 | 13 | 6 | 7 |  |
T infiltrate | Â | Â | Â | 0.043 |
 T1 | 19 | 17 | 2 |  |
 T2 | 10 | 6 | 4 |  |
 T3 | 64 | 36 | 28 |  |
 T4 | 46 | 25 | 21 |  |
Lymphatic metastasis (N) | Â | Â | Â | 0.209 |
 N0 | 42 | 29 | 13 |  |
 N1 | 22 | 14 | 8 |  |
 N2 | 32 | 17 | 15 |  |
 N3 | 42 | 24 | 18 |  |
Stage | Â | Â | Â | 0.012 |
 1 | 19 | 16 | 3 |  |
 2 | 41 | 28 | 13 |  |
 3 | 64 | 31 | 33 |  |
 4 | 15 | 9 | 6 |  |
Tumor metastasis (M) | Â | Â | Â | 0.877 |
 No | 124 | 75 | 49 |  |
 Yes | 16 | 10 | 6 |  |
Tumor size | Â | Â | Â | 0.753 |
 <5 cm | 39 | 22 | 17 |  |
 ≥5 cm | 57 | 34 | 23 |  |